HIV-associated neurocognitive disorders: is there a hidden epidemic?

The neurocognitive disorders associated with HIV (HAND) remain among the most common clinical disorders encountered in people infected with HIV, even in an era in which potent antiretroviral therapy is widely deployed. HAND is currently considered to encompass a hierarchy of progressively more sever

[1]  Michael J. Taylor,et al.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.

[2]  Jean-Marie Annoni,et al.  Cognitive dysfunction in HIV patients despite long-standing suppression of viremia , 2009, AIDS.

[3]  G. Lopardo,et al.  Good Neurocognitive Performance Measured by the International HIV Dementia Scale in Early HIV-1 Infection , 2009, Journal of acquired immune deficiency syndromes.

[4]  D. Clifford,et al.  Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance , 2009, AIDS.

[5]  Dianne Langford,et al.  HIV and antiretroviral therapy in the brain: neuronal injury and repair , 2008, Nature Reviews Neuroscience.

[6]  B. Brew,et al.  Biomarkers of HIV related central nervous system disease , 2008, International review of psychiatry.

[7]  J. Margolick,et al.  Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals , 2007, Neurology.

[8]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[9]  Justin C McArthur,et al.  The prevalence and incidence of neurocognitive impairment in the HAART era , 2007, AIDS.

[10]  E. Masliah,et al.  Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. , 2007, The Journal of infectious diseases.

[11]  N. McGrath,et al.  FREQUENCY OF AND RISK FACTORS FOR HIV DEMENTIA IN AN HIV CLINIC IN SUB-SAHARAN AFRICA , 2007, Neurology.

[12]  P. Maruff,et al.  Variable benefit in neuropsychological function in HIV-infected HAART-treated patients , 2006, Neurology.

[13]  O. Selnes,et al.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia , 2005, AIDS.

[14]  V. Valcour,et al.  Circulating proviral HIV DNA and HIV-associated dementia , 2005, AIDS.

[15]  K. Marder,et al.  Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia , 2004, Neurology.

[16]  I. Grant,et al.  CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults , 2004, Journal of Neuroimmunology.

[17]  P. Maruff,et al.  Antiretroviral therapy in HIV infection: are neurologically active drugs important? , 2004, Archives of neurology.

[18]  Bruce J Brew,et al.  Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy , 2003, AIDS.

[19]  N. Sacktor.  The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. , 2002, Journal of neurovirology.

[20]  B. Rovin,et al.  HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Becker,et al.  CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing , 2001, Neurology.

[22]  R. Mayeux,et al.  Finding the beginning or predicting the future? , 2000, Archives of neurology.

[23]  D. Clifford,et al.  Human immunodeficiency virus-associated dementia. , 2000, Archives of neurology.

[24]  J. Becker,et al.  Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy , 1999, Neurology.

[25]  O. Selnes,et al.  Variable progression of HIV‐associated dementia , 1998, Neurology.

[26]  D. Roden,et al.  The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.

[27]  G. Rezza,et al.  AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987–93) and differential incidence according to mode of transmission of HIV-1 infection , 1996, Journal of the Neurological Sciences.

[28]  O. Selnes,et al.  HIV Dementia Scale: a rapid screening test. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[29]  J. Becker,et al.  Dementia in AIDS patients , 1993, Neurology.

[30]  H. Morgenstern,et al.  Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the multicenter AIDS Cohort Study (MACS). , 1993, Journal of acquired immune deficiency syndromes.

[31]  R. Janssen,et al.  Epidemiology of human immunodeficiency virus encephalopathy in the United States , 1992, Neurology.

[32]  J. Phair,et al.  Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV‐1–infected individuals: Results from the multicenter AIDS cohort study , 1989, Annals of neurology.

[33]  B. Brew,et al.  NeuroAIDS in the Asia Pacific Region , 2011, Journal of NeuroVirology.

[34]  I. Grant,et al.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. , 2008, Archives of neurology.

[35]  K. Marder,et al.  An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. , 2007, Archives of neurology.